UBS has revised its price target for IBM to $150 after the release of the company's quarterly results, while still maintaining a "Sell" rating on the stock.
According to analyst David Vogt, IBM's financial figures were mixed, indicating a cautious outlook despite the increase in the price target.
This update is part of UBS's ongoing analysis of major tech companies, reflecting the bank's strategic approach to investment recommendations in the current market environment. Investors should consider the implications of these mixed results when evaluating their positions in IBM.